Man Group plc - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 80 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Man Group plc ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$1,975,000
+16.7%
37,391
+35.4%
0.01%
-11.1%
Q2 2020$1,692,000
-9.8%
27,611
-16.7%
0.01%
-25.0%
Q1 2020$1,876,000
-27.5%
33,161
-27.1%
0.01%
+33.3%
Q4 2019$2,589,000
+15.0%
45,465
+8.0%
0.01%
+12.5%
Q3 2019$2,252,000
-4.0%
42,086
+7.1%
0.01%0.0%
Q2 2019$2,346,000
+10.8%
39,286
+15.7%
0.01%0.0%
Q1 2019$2,117,000
+2.6%
33,963
-0.3%
0.01%
-11.1%
Q4 2018$2,064,000
+3.3%
34,063
-0.3%
0.01%
+28.6%
Q3 2018$1,998,000
+33.5%
34,163
+2.4%
0.01%
+16.7%
Q2 2018$1,497,000
-9.8%
33,363
-10.8%
0.01%
-25.0%
Q1 2018$1,659,00037,4230.01%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q2 2018
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 385,954$16,723,00010.02%
JW Asset Management, LLC 73,649$3,191,0003.40%
Elk Creek Partners, LLC 168,714$7,310,0000.43%
NORTHPOINTE CAPITAL LLC 80,710$3,497,0000.39%
Ativo Capital Management LLC 33,096$1,434,0000.38%
RICE HALL JAMES & ASSOCIATES, LLC 155,318$6,730,0000.26%
ISTHMUS PARTNERS, LLC 17,406$754,0000.20%
Matarin Capital Management, LLC 48,952$2,121,090,0000.16%
GLOBEFLEX CAPITAL L P 4,324$187,0000.05%
Summit Trail Advisors, LLC 6,797$295,0000.04%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders